Clovis Oncology Inc (NASDAQ:CLVS)
| 5.66 Delayed Data As of 4:03pm ET |  -0.115 / -1.99%Today’s Change | 4.08 Today|||52-Week Range 11.10 | +17.92% Year-to-Date |
Latest CLVS News | Press Releases
| Clovis Oncology Stock Is Believed To Be Possible Value Trap Apr 18 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 5.78 |
| Today’s open | 5.90 |
| Day’s range | 5.48 - 5.80 |
| Volume | 262,032 |
| Average volume (3 months) | 11,155,763 |
| Market cap | $624.6M |
Data as of 4:03pm ET, 04/20/2021
Growth & Valuation
| Earnings growth (last year) | +41.08% |
| Earnings growth (this year) | +39.92% |
| Earnings growth (next 5 years) | +63.10% |
| Revenue growth (last year) | +15.05% |
| P/E ratio | NM |
| Price/Sales | 2.46 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRNXCrinetics Pharmaceut... | +0.43 | +2.66% |
| IDYAIDEAYA Biosciences I... | +0.20 | +1.06% |
| EVLOEvelo Biosciences In... | -0.63 | -5.48% |
| ---- |
Data as of 3:59pm ET, 04/20/2021
Financials
| Next reporting date | May 11, 2021 |
| EPS forecast (this quarter) | -$0.68 |
| Annual revenue (last year) | $164.5M |
| Annual profit (last year) | -$369.2M |
| Net profit margin | -224.41% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
